Coat colour changes associated with cabergoline administration in bitches.
Cabergoline or bromocriptine were administered orally to 60 bitches at doses of 5 microg/kg and 15 microg/kg daily, respectively, for two to 45 days for the treatment of pseudopregnancy or for oestrus induction. Seven of the dogs which received cabergoline for more than 14 days developed coat colour changes from the second week of administration to the next coat shedding. Of these, fawn-coloured bitches developed a yellowish coat colour while Argentine boar hounds became black spotted, mainly on their extremities. In previous untreated oestrous periods, these bitches had shown no coat colour changes. It is concluded that a colour shift in certain haircoats of particular breeds could be mediated through the inhibition of the secretion of melanocyte-stimulating hormone by the administration of the dopaminergic agonist cabergoline for more than two weeks. Transient coat colour changes should be considered a possible side effect when planning long-term treatment with dopaminergic agonists in dogs.
Gobello
C
C
Small Animal Clinics, Faculty of Veterinary Sciences (CC 296), National University of La Plata, Argentina.
Castex
G
G
Broglia
G
G
Corrada
Y
Y
D000818:Animals; D001971:Bromocriptine / Q000627:therapeutic use; D000077465:Cabergoline; D004283:Dog Diseases / Q000139:chemically induced*; D004285:Dogs; D018491:Dopamine Agonists / Q000009:adverse effects* / Q000627:therapeutic use; D004873:Ergolines / Q000009:adverse effects* / Q000627:therapeutic use; D030762:Estrous Cycle / Q000187:drug effects; D005260:Female; D006200:Hair Color / Q000187:drug effects*; D009074:Melanocyte-Stimulating Hormones / Q000378:metabolism / Q000494:pharmacology; D010375:Pedigree; D010858:Pigmentation; D011555:Pseudopregnancy / Q000188:drug therapy / Q000662:veterinary*
D018491:Dopamine Agonists; D004873:Ergolines; D001971:Bromocriptine; D009074:Melanocyte-Stimulating Hormones; D000077465:Cabergoline